Optometrists in South Lyon, MI Accepting Medicare

7 Optometrists found. Showing 1 - 7

Dr. Rhonda Marie Bifano, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 317 N Lafayette St, South Lyon, MI 48178 Phone: 248-446-1146    Fax: 248-446-1350

First Optometry Optometrist Medicare: Medicare Enrolled Practice Location: 22371 Pontiac Trl, South Lyon, MI 48178 Phone: 248-437-7600    Fax: 248-437-0143

Oakland Vision Services Optometrist Medicare: Medicare Enrolled Practice Location: 608 N Lafayette St, South Lyon, MI 48178 Phone: 248-437-3351    Fax: 248-437-0738

Bifano Eye Care Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 317 N Lafayette St, South Lyon, MI 48178 Phone: 248-446-1146    Fax: 248-446-1350

Philip Kontry, OD PC Optometrist Medicare: Medicare Enrolled Practice Location: 22371 Pontiac Trl, South Lyon, MI 48178 Phone: 248-437-7600

Dr. Roger B Haag, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 107 N Lafayette St, South Lyon, MI 48178 Phone: 248-437-2002    Fax: 248-437-6838

Oakland Vision Optometrist Medicare: Medicare Enrolled Practice Location: 608 N Lafayette St, South Lyon, MI 48178 Phone: 248-437-3351

News Archive

Red colobus monkeys in Uganda found to harbor antibodies to an unknown orthopoxvirus

Researchers report this month that red colobus monkeys in a park in western Uganda have been exposed to an unknown orthopoxvirus, a pathogen related to the viruses that cause smallpox, monkeypox and cowpox. Most of the monkeys screened harbor antibodies to a virus that is similar - but not identical - to known orthopoxviruses.

New oxytocin chemical sensor could be first step towards early diagnosis of autism

Is it going to be possible to detect features of autism at birth? At the Institute of Physical Chemistry of the Polish Academy of Sciences in Warsaw a sensor has come into being that means this may become a reality.

Eli Lilly and Kowa Pharmaceuticals America to co-promote LIVALO in the U.S

Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.

Cardiovascular conditions may be overlooked in bipolar disorder

Cardiovascular comorbidities may be going under-recognized and undertreated in patients with bipolar disorder, say UK researchers.

Read more Medical News

› Verified 4 days ago